Bellevue Group AG Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$551.1B
Holdings
130
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (130 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | BIBProShares Trust | 18,000 | $736.0M | 0.13% | |
| 102 | EX9Exelixis, Inc. | 170,000 | $680.0M | 0.12% | |
| 103 | ESPREsperion Therapeutics Inc. | 40,000 | $676.0M | 0.12% | |
| 104 | IBBiSHARES Trust | 2,500 | $652.0M | 0.12% | |
| 105 | —Kite Pharma, Inc. | 14,000 | $643.0M | 0.12% | |
| 106 | RAREUltragenyx Pharmaceuticals Inc. | 10,000 | $633.0M | 0.11% | |
| 107 | —Team Health Holdings Inc. | 15,000 | $627.0M | 0.11% | |
| 108 | —Celldex Therapeutics, Inc. | 160,000 | $605.0M | 0.11% | |
| 109 | LABUUSDDirexion Shares ETF Trust | 20,175 | $553.0M | 0.10% | |
| 110 | MYGNMyriad Genetics, Inc. | 14,000 | $524.0M | 0.10% | |
| 111 | I9DNArbutus Biopharm Corporation | 125,000 | $516.0M | 0.09% | |
| 112 | PODDInsulet Corporation | 15,000 | $497.0M | 0.09% | |
| 113 | RMEResMed Inc. | 8,000 | $463.0M | 0.08% | |
| 114 | NVROEURNevro Corp. | 7,500 | $422.0M | 0.08% | |
| 115 | PENPenumbra, Inc. | 8,000 | $368.0M | 0.07% | |
| 116 | —Juniper Pharmaceuticals Inc. | 50,000 | $331.0M | 0.06% | |
| 117 | —Endocyte, Inc. | 100,000 | $310.0M | 0.06% | |
| 118 | THCTenet Healthcare Corporation | 10,000 | $289.0M | 0.05% | |
| 119 | IMGNEURImmunoGen, Inc. | 30,000 | $256.0M | 0.05% | |
| 120 | PTCTPTC Therapeutics Inc. | 35,000 | $225.0M | 0.04% | |
| 121 | TBPHTheravance Biopharma, Inc. | 11,248 | $215.0M | 0.04% | |
| 122 | —XOMA Corporation | 225,000 | $174.0M | 0.03% | |
| 123 | —Heartware International, Inc. | 5,000 | $157.0M | 0.03% | |
| 124 | —Zafgen, Inc. | 20,000 | $134.0M | 0.02% | |
| 125 | SGRYSurgery Partners, Inc. | 10,000 | $133.0M | 0.02% | |
| 126 | GONGeron Corporation | 45,000 | $131.0M | 0.02% | |
| 127 | TTPHEURTetraphase Pharmaceuticals, Inc. | 22,000 | $102.0M | 0.02% | |
| 128 | CLDNEUREiger BioPharmaceuticals, Inc. | 3,333 | $56.0M | 0.01% | |
| 129 | —Asterias Biotherapeutics, Inc. | 1,875 | $9.0M | 0.00% | |
| 130 | —Biotime Inc. | 2,294 | $1.0M | 0.00% |
PreviousPage 2 of 2